Epub 2020 Jun 22. These drugs display binding to pro-survival Bcl-2 proteins resulting in actuation of apoptosis of cancer cells. Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy? This website is intended for pathologists and laboratory personnel but not for patients.
We welcome suggestions or questions about using the website. 2008 Jun;15(6):977-87. doi: 10.1038/cdd.2008.37.

Semin Cancer Biol.

Bcl-2 overexpression is commonly associated with various cancers including breast cancer, prostate cancer, B-cell lymphomas and colorectal adenocarcinomas etc. Surprisingly, BCL2 overexpression in osteoblasts causes osteocyte apoptosis (PLoS One 2011;6:e27487) Diagrams / tables. Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics. HHS Please enable it to take advantage of the complete set of features!

2020 Jul;39(31):5338-5357. doi: 10.1038/s41388-020-1372-7. © Copyright PathologyOutlines.com, Inc. Click, Kumar: Robbins & Cotran Pathologic Basis of Disease, Eighth Edition, 2009, McPherson: Henry's Clinical Diagnosis and Management by Laboratory Methods, Twenty Second Edition, 2011 (Chapter 33), Encodes 25 kDa protein, mainly localized to inner mitochondrial membrane; also endoplasmic reticulum and nuclear envelope, BCL2 overexpression increase lifespan of B cells; may maintain memory B cells, plasma cells and neurons by prolonging life span without cell division, May participate in ion channel formation and alteration of membrane permeability, necessary for initiation of apoptosis, Non-phosphorylated BCL2 inhibits apoptosis, and Bax homodimers normally cause apoptosis; Bax can bind to and inhibit non-phosphorylated BCL2, promoting apoptosis, Epstein-Barr virus latent membrane protein-1 (LMP-1) interacts with BCL2 promoter, leading to prolonged lifespan for B cells, Surprisingly, BCL2 overexpression in osteoblasts causes osteocyte apoptosis (, (1) Distinguish follicular hyperplasia of lymph node (germinal centers are BCL2 negative) from follicular lymphoma (germinal centers are BCL2+); BCL2 usually overexpressed in follicular lymphoma due to t(14,18)(q32;q21), which brings BCL2 gene adjacent to active immunoglobulin heavy chain (IgH) gene; however, some follicular lymphomas are BCL2 negative (, (2) Detect immature enteric ganglion cells in pediatric intestinal pseudo-obstruction (, (3) Diffuse large cell lymphoma: adverse prognostic factor in some studies (, (4) Myelodysplastic syndrome: increased expression associated with progression, (5) May have prognostic value in early stage breast cancer (, Lymph node: small B lymphocytes in mantle zone and cells within T cell areas, Adrenal cortex, melanocyties, thymus-medullary cells, thyroid gland solid cell nests, Immature (but not mature) small ganglion cells.


Functional genomics identifies new synergistic therapies for retinoblastoma. Copyright © 2019 Elsevier B.V. All rights reserved.  |  Proteins of the B-cell lymphoma-2 (BCL-2) family control the intrinsic apoptosis pathway. BCL2 translocation in follicular lymphoma.

Apoptosis is one of the major mechanisms exhibited in response to cell death and induction of apoptosis in tumour cells signifies a potential target for cancer therapy. Mitochondrial control … negative, the predominant pattern, Follicular lymphoma of thyroid: t(14;18) negative / BCL2 negative (left) versus positive (right), Solitary fibrous tumor: left/middle-ear, right-CNS.  |  Mol Cancer Ther. BCL2 translocation in follicular lymphoma, Normal: lymph node(mantle zone and T cellsare positive but germinal center is negative), Burkitt lymphoma: doi: 10.1038/onc.2009.52. The first BH3 mimetics discovered as an outcome of structure-based drug design and Nuclear Magnetic Resonance (NMR)-based screening was ABT-263, an N-acylsulfonamide analogue.

Incorrect: anaplastic large cell lymphoma is primarily associated with t(2;5). B-cell lymphoma-2 (Bcl-2)-family proteins play an important role in regulating the induction of apoptosis. BCL-2: Long and winding path from discovery to therapeutic target. Epub 2020 Jun 23. 2020 Sep;94(9):3125-3136. doi: 10.1007/s00204-020-02816-0. Research investigations underlying Bcl-2 target have resulted in the generation of small molecule inhibitors, named as 'BH3-mimetics' (Bcl-2 homology 3 mimetics). Bcl-2 family proteins play a key role in regulation of the apoptotic pathway. 2013 Sep;12(9):1691-700. doi: 10.1158/1535-7163.MCT-13-0058. Bcl-2 family proteins play a key role in regulation of the apoptotic pathway.

Several Bcl-2 inhibitors as small molecules are under clinical development and the results indicated that these molecules alone or in combination could be of potential application in cancer therapy.

Thus, Bcl-2 is a novel anti-cancer target attracting medicinal chemists across the globe.  |  Bim, Puma and Noxa upregulation by Naftopidil sensitizes ovarian cancer to the BH3-mimetic ABT-737 and the MEK inhibitor Trametinib.

Epub 2017 Feb 3. Epub 2008 Mar 28. Sci Rep. 2020 Sep 16;10(1):15188. doi: 10.1038/s41598-020-72058-8. Synergistic effects of Bcl-2 inhibitors with AZD9291 on overcoming the acquired resistance of AZD9291 in H1975 cells. Kontar S, Imrichova D, Bertova A, Mackova K, Poturnayova A, Sulova Z, Breier A. Molecules. 2020 Apr 30;25(9):2093. doi: 10.3390/molecules25092093. Regulated cell death pathways: New twists in modulation of BCL2 family function Nidhish Sasi, Misun Hwang, Jerry Jaboin, Ildiko Csiki, and Bo Lu Department of Radiation Oncology, Vanderbilt Ingram Cancer Center, Nashville, Tennessee

The pro-apoptotic BCL-2 proteins BAX and BAK can commit a cell to its programmed death by permeabilizing the outer mitochondrial membrane (OMM) and subsequent initiation of the caspase cascade. This site needs JavaScript to work properly.

2020 May 18;11(5):380. doi: 10.1038/s41419-020-2588-8. Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/. Perhaps the best understood pathway is that in the worm C. elegans, where detailed genetic studies have shown that two Bcl-2 related proteins (pro-apoptotic EGL-1 and pro-survival CED-9) are essential for controlling developmentally programmed somatic cell deaths (Horvitz, 1999). AFIP images. Bcl-2 inhibitors (inhibiting targets of signaling pathways) used for various assays, some have … Giant cell angiofibroma, hemangiopericytoma, large cell neuroendocrine carcinoma (salivary glands), low grade fibromyxoid sarcoma of soft tissue, lymphoepithelioma-like carcinoma, melanoma (uvea, Sclerosing epithelioid fibrosarcoma, small cell carcinoma (breast), solitary fibrous tumor, spindle cell epithelioma of vagina (, Anaplastic lymphoma, apocrine benign / malignant lesions, benign fibrous histiocytoma, lymphoid hyperplasia (marginal zone cells in hyperplastic areas are BCL2+, germinal centers are BCL2-), lymphoplasmayctic lymphoma. Aubry A, Pearson JD, Huang K, Livne-Bar I, Ahmad M, Jagadeesan M, Khetan V, Ketela T, Brown KR, Yu T, Lu S, Wrana JL, Moffat J, Bremner R. Oncogene. Incorrect: Burkitt lymphoma is primarily associated with t(8;14), also t(2;8) and t(8;22). Thrombocytopenia a major dose-limiting toxicity, associated with ABT-263 had provoked the invention of a highly selective Bcl-2 inhibitor venetoclax.